Latest News from Spectator
Spectator
an hour ago
- Business
- Spectator
Zelensky is in an impossible position
The Ukrainian president said this week he hopes the war will end by next June. Not this summer. Not this year. But in 12 months' time. Sanctions, he believes, and four years of gruesome war will finally hit the Russian economy, pushing it into a deep budget deficit. The IMF's latest forecast sort of backs this up. Russia's GDP growth is set to slow to 0.9 per cent next year, down from over 4 per cent in 2024. Most of Russia's workforce is already employed and its central bank's key interest rate is at 21 per cent. Still, for many Ukrainians, Russia's downfall feels like yet another fairy tale. They've heard it all before. In the first days of the full-scale invasion, Ukrainians were told it would be over in 'two to three weeks'. And when those weeks passed – again, 'two to three weeks'. Russia's stockpiles had almost run out of missiles, Ukrainians were told.
Spectator
an hour ago
- Politics
- Spectator
Israel faces a brutal choice
For months, Israel has faced a relentless barrage of criticism over its conduct in Gaza – from western governments, UN agencies, and media outlets that once claimed to be her allies. Central to the condemnation are the humanitarian circumstances: civilian suffering, limited aid access, and Israel's temporary obstruction of some relief efforts. What has gone largely unreported, however, is that the bold new strategy in place may now be altering that equation entirely – a direct aid delivery mechanism, led by American contractors, that is not only reaching civilians more effectively but also weakening Hamas from within. You would never have guessed from the way some world leaders have condemned it. For years, aid to Gaza flowed through Hamas-linked channels. The results were predictable. Supplies were diverted, skimmed, taxed, or hoarded by Hamas and resold at inflated prices. The very system intended to alleviate suffering ended up financing the terror group's entrenchment and violence.
Spectator
9 hours ago
- Politics
- Spectator
Should cannabis be decriminalised?
London Mayor Sir Sadiq Khan has called for possession of small amounts of cannabis to be decriminalised following a report by the London Drugs Commission. The report has made 42 recommendations, which include removing natural cannabis from the Misuse of Drugs Act. Former cabinet minister, now Labour peer, Charlie Falconer and Tory MP Dr Neil Shastri-Hurst join Lucy Dunn to discuss whether now is the time to decriminalise cannabis. For Lord Falconer, who chaired the Commission, the present law doesn't work and he explains the principles behind the review; Neil, however, believes that the proposals send the wrong message that cannabis is harmless. He argues that a balance needs to be found between robust enforcement and compassion for families and friends also affected by the behaviour of drug users. They both agree on the diagnosis, but how do you combat the issue? Produced by Patrick Gibbons.
Spectator
10 hours ago
- Spectator
Where have all the Japanese tourists gone?
Is the Japanese tourist, for so long in good numbers a welcome and reliable fixture at our most famous tourist spots, now in serious decline? The number of Japanese travelling abroad is still well down on pre-Covid times and with government data just released revealing that fewer and fewer Japanese even hold a passport, the slump could be prolonged, which would be disastrous for the UK tourism and hospitality industry. According to the Japanese government, only around 17 per cent of Japanese adults currently hold a passport, a significantly lower rate than the US and UK (50 and 85 per cent respectively). It seems the Japanese are less and less inclined to travel. The reasons are not difficult to identify but quite hard to address. They fall into two categories:medical (or perhaps psychological) and financial. The first is the legacy of the Covid restrictions that for a while returned Japan to its exclusionary Sakoku period of splendid isolation.
Spectator
10 hours ago
- Science
- Spectator
What's wrong with using Xenon to climb Everest?
Reaching the top of the world and returning to London within a week without so much as stopping for a coffee in Kathmandu sounds like the stuff dreams are made of. But on 21 May 2025, four former members of the British special forces turned this dream into reality when they stood on the summit of Mount Everest four days and 11 hours after leaving the UK. Their secret was to inhale Xenon two weeks prior to the climb, a gas well known to anaesthetists, but so far unheard of in mountaineering. 'Although Xenon has worked well in clinical studies, it is very rarely used for patients in the UK. It is expensive and complex to administer with no significant benefits over established agents,' says Dr Mike Grocott, a professor of anaesthesia and critical care medicine at the University of Southampton.
